Notícias Lixte Biotechnology Holdings Inc - LIXT | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Lixte Biotechnology Holdings Inc (LIXT)
Lixte Biotechnology Holdings Inc (LIXT) Notícias

Lixte Biotechnology Holdings Inc (LIXT)

1,30

0,0299

( 2,35% )

Atualizado: 14:18:40

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement

LIXTE Receives U.S. Patent Issue Notification for Immune Oncology

Form 8-K - Current report

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company

Form 8-K - Current report

Form 8-K - Current report

LIXTE Biotechnology Provides Update On Recent Activities and Developments

LIXTE Biotechnology Holdings to Present at Two Investor Conferences

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Lixte Biotechnology

Vanguard Short Term Corp...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições